Work

Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients with Unresectable Esophageal and Gastroesophageal Adenocarcinoma

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e3181d7776d

Authors: Maryam B. Lustberg, Tanios Bekaii-Saab, Donn Young, Gregory Otterson, William Burak, Abbas Abbas, Barbara McCracken-Bussa, Mark E. Lustberg, Miguel A. Villalona-Calero

Institution: The Ohio State University

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Cancer Institute, National Center for Research Resources

Awards: The Ohio State University Center for Clinical and Translational Science (UL1), G364506074, Phase II randomized trial of CPT-11 and Mitomycin C, G6869192552, Massey Cancer Center - Cancer Center Support Grant, OSU K12 Training Grant in Oncology

OpenAlex ID: W1970287385

FWCI: 1.011

Cites: 26

Cited by: 16

Related to: 10